In vivo consequences of M1-receptor activation by talsaclidine
- 21 February 1997
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 60 (13-14), 977-984
- https://doi.org/10.1016/s0024-3205(97)00037-4
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Phase I clinical trials with WAL 2014, a new muscarinic agonist for the treatment of Alzheimer's diseaseLife Sciences, 1995
- WAL 2014 - A muscarinic agonist with preferential neuron-stimulating propertiesLife Sciences, 1993
- Muscarinic receptor differentiationPharmacology & Therapeutics, 1988
- Measurement of blood flow by thermodilutionThe American Journal of Cardiology, 1972
- Activity of the Adrenal Medulla and its RegulationPhysiological Reviews, 1964
- Versuchsanordnung zu Untersuchungen an der BronchiàlmuskulaturNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1940